Chester County News and Community Website
WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) said the U.S. Food and Drug Administration has not identified bioequivalence deficiencies in its abbreviated new drug application for a preservative-free ketamine …
NRx Says FDA Finds No Bioequivalence Issues in Ketamine Filing Read More WILMINGTON, DE — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) said it has received written confirmation from the U.S. Food and Drug Administration supporting a path toward approval of its depression treatment …
NRx Says FDA Will Review NRX-100 Without New Trials Read More
WILMINGTON, DE — Phreesia announced that Tiffany McGee, assistant general counsel for commercial contracts, has been named to The Software Report’s 2025 list of Top Women Leaders in Software.
Phreesia Attorney Tiffany McGee Named Top Women Leaders List Read More
WILMINGTON, DE — The LYCRA Company launched its COOLMAX CloakFX fiber at the Performance Days trade show in Munich on March 18–19, introducing a textile designed to reduce the visible …
LYCRA Launches COOLMAX CloakFX Fiber at Munich Textile Show Read More
WILMINGTON, DE — Intel 471 announced that its Verity471 platform has been named a finalist in the 2026 SC Awards in the Best Threat Intelligence Technology category.
Intel 471 Named SC Awards Finalist for Threat Intelligence Platform Read More WILMINGTON, DE — Phreesia announced it has been named to the 2026 Capterra Shortlist for appointment scheduling, a ranking based on user reviews and product visibility data.
Phreesia Named to 2026 Capterra Shortlist for Scheduling Software Read More
WILMINGTON, DE — Documo announced it has joined the PointClickCare Marketplace, integrating its document exchange and workflow automation platform with PointClickCare systems to help healthcare organizations process fax-based communications more …
Documo Integrates Platform With PointClickCare Marketplace Read More WILMINGTON, DE — Trialbee announced the appointment of life sciences executive Rick Riegel to its board of directors as the company expands its operations in global clinical trial patient recruitment.
Trialbee Appoints Rick Riegel to Board of Directors Read More
WILMINGTON, DE — AstraZeneca (Nasdaq: AZN) announced a national public health campaign encouraging Americans to speak with their doctors about cancer risk and screening, partnering with actor Joshua Jackson and …
AstraZeneca Launches Cancer Screening Campaign With Joshua Jackson Read More
WILMINGTON, DE — The U.S. Food and Drug Administration has accepted and granted Priority Review to a supplemental application for ENHERTU, a breast cancer treatment developed by AstraZeneca and Daiichi …
FDA Grants Priority Review to ENHERTU for Early Breast Cancer Use Read More